Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

JP Morgan Downgrades Oak Street Health to Neutral, Raises Price Target to $39

Author: Benzinga Newsdesk | February 23, 2023 06:47am
JP Morgan analyst Lisa Gill downgrades Oak Street Health (NYSE:OSH) from Overweight to Neutral and raises the price target from $35 to $39.

Posted In: OSH